Elevated PSA clinical trials at UCLA

1 in progress, 0 open to eligible people

PSMA PET Combined With MRI for the Detection of PCa
Sorry, in progress, not accepting new patients
This is an open label, longitudinal Phase 3 study of prostate specific membrane antigen (PSMA) positron emission tomography (PET) combined with magnetic resonance imaging (MRI) compared to standard of care (SOC) for the detection of prostate cancer (PCa).
Los Angeles, California and other locations

Last updated: October 15, 2026